Adaptive Biotechnologies
ADPT
#5169
Rank
A$1.83 B
Marketcap
$12.36
Share price
0.81%
Change (1 day)
198.14%
Change (1 year)

Adaptive Biotechnologies (ADPT) - Cash on Hand

Cash on Hand as of December 2024 : A$0.36 Billion

According to Adaptive Biotechnologies 's latest financial reports the company has A$0.36 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Adaptive Biotechnologies - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.35 B-29.71%
2023-12-31A$0.50 B-30.55%
2022-12-31A$0.73 B50.33%
2021-12-31A$0.48 B-45.59%
2020-12-31A$0.89 B8.64%
2019-12-31A$0.82 B251.74%
2018-12-31A$0.23 B-4.83%
2017-12-31A$0.24 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$3.19 B 769.57%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.14 B-61.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$61.19 M-83.36%๐Ÿ‡บ๐Ÿ‡ธ USA
A$98.73 M-73.15%๐Ÿ‡บ๐Ÿ‡ธ USA